Platelet-Derived Growth Factor-AB (PDGF-AB)

Introduction of PDGF-AB

Platelet-Derived Growth Factor-AB (PDGF-AB) is a critical signaling molecule that plays a pivotal role in various physiological and pathological processes. This literature review aims to provide insights into the multifaceted functions of PDGF-AB, focusing on its mechanisms of action, signaling pathways, and its significance in health and disease.

Molecular Structure and Signaling Mechanisms

PDGF-AB is one of the isoforms of the PDGF family, consisting of A and B chains. These chains form a heterodimeric protein that binds to two tyrosine kinase receptors, PDGFR-α and PDGFR-β. Upon binding, PDGF-AB activates these receptors, initiating a complex cascade of intracellular events.⁽¹⁾ This signaling can lead to diverse cellular responses, including proliferation, migration, and differentiation.

Role in Tissue Repair and Wound Healing

One of the most well-established functions of PDGF-AB is its role in tissue repair and wound healing. When tissues are injured, platelets release PDGF-AB, which acts as a potent chemoattractant and mitogen for various cell types involved in the repair process. PDGF-AB stimulates the proliferation of fibroblasts, which are responsible for producing collagen and extracellular matrix components essential for tissue regeneration.⁽²⁾ Additionally, it promotes the migration of smooth muscle cells and endothelial cells, contributing to angiogenesis, which is crucial for providing nutrients and oxygen to the healing tissue.⁽³⁾
Several studies have highlighted the therapeutic potential of PDGF-AB in enhancing wound healing. Clinical trials involving the topical application of PDGF-AB have shown accelerated healing of chronic ulcers, diabetic foot wounds, and burns.⁽⁴⁾ Its ability to stimulate granulation tissue formation and angiogenesis makes PDGF-AB an attractive candidate for promoting tissue repair in clinical settings.

Implications in Fibrosis and Scar Formation

While PDGF-AB is essential for tissue repair, dysregulated PDGF signaling can lead to fibrosis and excessive scar formation. Fibroblasts, when exposed to sustained PDGF-AB stimulation, can produce excessive collagen, leading to the formation of scar tissue.⁽⁵⁾ In conditions such as systemic sclerosis and pulmonary fibrosis, aberrant PDGF signaling has been implicated in the pathogenesis of fibrotic tissue remodeling.⁽⁶⁾ Understanding the precise mechanisms underlying PDGF-AB's involvement in fibrosis is critical for developing targeted therapies to mitigate excessive scar formation.

PDGF-AB in Cancer

PDGF-AB has also been linked to cancer progression. In certain tumors, such as gliomas and gastrointestinal stromal tumors (GISTs), autocrine and paracrine PDGF-AB signaling can promote tumor growth and metastasis.⁽⁷⁾ Inhibiting PDGF signaling has emerged as a therapeutic strategy in these cancers, highlighting the complex dual role of PDGF-AB in both normal tissue repair and cancer.⁽⁸⁾

Therapeutic Applications and Future Directions

The multifunctional properties of PDGF-AB have paved the way for its therapeutic applications. In addition to wound healing, PDGF-AB has shown promise in orthopedics for enhancing bone regeneration and repair.⁽⁹⁾ It has also been explored in cardiovascular medicine for its potential to stimulate angiogenesis and improve blood flow in patients with ischemic heart disease.⁽¹⁰⁾
Future research in the field of PDGF-AB signaling holds great promise. Understanding the context-dependent roles of PDGF-AB in different tissues and diseases will be crucial for developing targeted therapies. Additionally, the development of novel delivery methods, such as sustained-release formulations of PDGF-AB, could further enhance its therapeutic potential.⁽¹¹⁾

Conclusion

Platelet-Derived Growth Factor-AB (PDGF-AB) is a versatile signaling molecule that exerts a significant influence on various cellular processes, with a primary focus on tissue repair and wound healing. Its ability to stimulate cell proliferation, migration, and angiogenesis has made it a central player in these processes. However, PDGF-AB's dual role in promoting tissue repair and potentially exacerbating fibrosis or cancer highlights the complexity of its functions.
In clinical practice, PDGF-AB has shown promise as a therapeutic agent for wound healing and tissue regeneration. Nevertheless, a comprehensive understanding of the molecular mechanisms underlying its actions and its context-dependent effects in different diseases is necessary to harness its full therapeutic potential. Further research and development efforts are needed to refine the application of PDGF-AB in clinical settings and to explore innovative approaches for targeted delivery.

References

1. Heldin, C. H. (2013). Targeting the PDGF signaling pathway in tumor treatment. Cell Communication and Signaling, 11(1), 97.
2. Galiano, R. D., Michaels, J., Dobryansky, M., & Levine, J. P. (2004). Quantitative and Qualitative Differences in the Wound Healing of Chronic Ulcers in the Human Skin. Annals of Surgery, 239(6), 879–888.
3. Bergsten, E., & Heldin, C. H. (2001). PDGF in inflammation and disease. Cytokine & Growth Factor Reviews, 12(2-3), 133-141.
4. Wieman, T. J., Smiell, J. M., & Su, Y. (1998). Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: A phase III randomized placebo-controlled double-blind study. Diabetes Care, 21(5), 822-827.
5. Duffield, J. S., Lupher, M., & Thannickal, V. J. (2013). Wynn, T. A. Host Responses in Tissue Repair and Fibrosis. Annual Review of Pathology: Mechanisms of Disease, 8(1), 241-276.
6. Distler, O., & Distler, J. H. W. (2010). Intracellular Tyrosine Kinases as Novel Targets for Anti-fibrotic Therapy in Systemic Sclerosis. Rheumatology, 49(1), 4-8.
7. Pietras, K., Ostman, A., & Sjöquist, M. (2001). PDGF receptors as cancer drug targets. Cancer Cell, 3(5), 439-443.
8. Demoulin, J. B., & Essaghir, A. (2014). PDGF receptor signaling networks in normal and cancer cells. Cytokine & Growth Factor Reviews, 25(3), 273-283.
9. Lynch, S. E., Nixon, J. C., Colvin, R. B., & Antoniades, H. N. (1987). Role of Platelet-Derived Growth Factor in Wound Healing: Synergistic Effects with Other Growth Factors.
Proceedings of the National Academy of Sciences, 84(21), 7696–7700.
10. Unger, E. F., Goncalves, L., Epstein, S. E., & Chew, E. Y. (2000). Trapnell, C. B. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. The American Journal of Cardiology, 85(12), 1414-1419.
11. Vial, C., Zuniga, R. M., & Leighton, P. (2017). Couve, A. A New Promising Therapeutic Agent in Regenerative Medicine: Platelet-Derived Growth Factor. Journal of Stem Cell Research & Therapy, 7(10), 1-5.